Coya TherapeuticsCOYA
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 54 institutions reported holding Coya Therapeutics Inc. (COYA) in their 13F filings, down 2 from Q1 2026. 5 opened new positions and 7 sold out. The largest holders were Greenlight Capital (DME Capital Management) ($13.7M), Vanguard Capital Management LLC ($4.9M) and Alyeska Investment Group, L.P. ($4.7M). 3 famous investors held it, including David Einhorn (0.3% of Greenlight Capital (DME Capital Management)'s portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Coya Therapeutics Inc.
- CUSIP
- 22407B108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $450K |
| Exits | 7 | $693K |
All 13F filers, Q1 2026 → Q2 2026: 498,261 shares bought and 830,252 shares sold, net −331,991 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 54 holders
| Greenlight Capital (DME Capital Management) | 0.35% | No change | 2,335,540 | $13.7M |
| Vanguard Capital Management LLC | 0.00% | Reduce -0.3% | 842,220 | $4.9M |
| Alyeska Investment Group, L.P. | 0.01% | No change | 800,000 | $4.7M |
| AIGH Capital Management LLC | 0.33% | Reduce -35.2% | 631,912 | $3.7M |
| CM Management, LLC | 1.49% | Add +6.7% | 400,000 | $2.3M |
| Private Management Group Inc. | 0.06% | Add +4.1% | 384,217 | $2.2M |
| Marshall Wace, LLP | 0.00% | Add +10.6% | 249,793 | $1.5M |
| Geode Capital Management, LLC | 0.00% | Reduce -2.2% | 228,243 | $1.3M |
| Renaissance Technologies | 0.00% | Add +85.6% | 192,986 | $1.1M |
| Prosight Management, LP | 0.17% | Reduce -59.6% | 170,000 | $995K |
| Dimensional Fund Advisors LP | 0.00% | Add +62.5% | 155,917 | $913K |
| Vanguard Fiduciary Trust Co. | 0.00% | Reduce -7.4% | 129,551 | $758K |
| Jones Financial Companies LLLP | 0.00% | Add +146.7% | 110,910 | $610K |
| BlackRock, Inc. | 0.00% | Add +23.7% | 102,408 | $599K |
| Prelude Capital Management, LLC | 0.04% | No change | 101,330 | $593K |
| JBF Capital, Inc. | 0.08% | No change | 100,006 | $585K |
| Royal Bank of Canada | 0.00% | Add +597.5% | 93,414 | $546K |
| Morgan Stanley | 0.00% | Reduce -4.2% | 82,106 | $480K |
| State Street Corp. | 0.00% | No change | 79,813 | $467K |
| Susquehanna International Group, LLP | 0.00% | Add +55.2% | 61,006 | $357K |
| Northern Trust Corp. | 0.00% | Add +11.5% | 45,072 | $264K |
| XTX Topco Ltd | 0.00% | Reduce -12.5% | 41,401 | $242K |
| ADAR1 Capital Management, LLC | 0.01% | No change | 40,900 | $239K |
| Long Corridor Asset Management Ltd | 0.09% | No change | 38,766 | $227K |
| Cetera Investment Advisers | 0.00% | Add +13.3% | 34,000 | $199K |
| Squarepoint Ops LLC | 0.00% | Reduce -17.8% | 33,260 | $195K |
| UBS Group AG | 0.00% | Reduce -14.2% | 33,088 | $194K |
| Quadrature Capital Ltd | 0.00% | New | 30,783 | $180K |
| Goldman Sachs Group Inc. | 0.00% | New | 26,180 | $153K |
| GHP Investment Advisors, Inc. | 0.01% | No change | 26,171 | $153K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 20,626 | $121K |
| Axq Capital, LP | 0.01% | New | 19,809 | $116K |
| Oppenheimer & Co. Inc. | 0.00% | No change | 18,000 | $105K |
| Jump Financial, LLC | 0.00% | Reduce -17.6% | 17,300 | $101K |
| Occudo Quantitative Strategies LP | 0.01% | Reduce -28.8% | 16,823 | $98K |
| Citadel Advisors | 0.00% | Reduce -22.3% | 13,105 | $77K |
| Allworth Financial LP | 0.00% | Add +1200.0% | 13,000 | $76K |
| Raymond James Financial Inc. | 0.00% | Reduce -12.4% | 10,225 | $60K |
| HighTower Advisors, LLC | 0.00% | No change | 10,029 | $59K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 10,000 | $59K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 5,879 | $34K |
| JPMorgan Chase & Co. | 0.00% | Add +3.6% | 5,181 | $31K |
| BNP Paribas Financial Markets | 0.00% | Reduce -44.4% | 4,763 | $28K |
| Bfsg, LLC | 0.00% | No change | 3,455 | $20K |
| IFP Advisors, Inc | 0.00% | Reduce -20.0% | 2,000 | $12K |
| Rockefeller Capital Management L.P. | 0.00% | No change | 2,000 | $12K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -11.0% | 820 | $5K |
| Wells Fargo & Company | 0.00% | No change | 500 | $3K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 500 | $3K |
| North Star Investment Management Corp. | 0.00% | No change | 340 | $2K |
| Barclays PLC | 0.00% | New | 113 | $661 |
| Arax Advisory Partners | 0.00% | New | 60 | $351 |
| Triumph Capital Management | 0.00% | No change | 50 | $292 |
| Caitong International Asset Management Co., Ltd | 0.00% | Add +1266.7% | 41 | $240 |
"% of holder's portfolio" is COYA's weight in each manager's 13F, not the share of Coya Therapeutics Inc. the manager owns.